Curtis Layton

Curtis Layton is the CEO and Co-Founder of Protillion Biosciences, a position held since May 2019. Prior to this, Curtis Layton served as a Research Scientist and Postdoctoral Research Fellow at Stanford University School of Medicine from February 2011 to May 2019. Earlier academic experience includes a Graduate Research Associate role at Duke University Medical Center from September 2003 to December 2010, where Curtis earned a Ph.D. in Computational Biology (Biochemistry). Curtis Layton's educational background comprises postdoctoral fellowships in Genetics and Biochemistry from Stanford University School of Medicine, as well as a B.S. in Zoology from Brigham Young University.